Roger Chammas Selected Research

Nucleophosmin

1/2014	Deregulated expression of Nucleophosmin 1 in gastric cancer and its clinicopathological implications.
8/2012	Quantitative proteomic analysis and functional studies reveal that nucleophosmin is involved in cell death in glioblastoma cell line transfected with siRNA.
8/2010	Proteomic analysis of low- to high-grade astrocytomas reveals an alteration of the expression level of raf kinase inhibitor protein and nucleophosmin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roger Chammas Research Topics

Disease

92	Neoplasms (Cancer) 01/2024 - 03/2006
39	Melanoma (Melanoma, Malignant) 10/2023 - 04/2005
15	Neoplasm Metastasis (Metastasis) 07/2022 - 07/2009
11	Breast Neoplasms (Breast Cancer) 12/2022 - 07/2009
9	Carcinogenesis 09/2021 - 04/2011
7	Carcinoma (Carcinomatosis) 06/2022 - 10/2007
7	Stomach Neoplasms (Stomach Cancer) 12/2018 - 01/2012
7	Renal Cell Carcinoma (Grawitz Tumor) 07/2013 - 10/2007
5	Infections 02/2016 - 02/2007
4	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 10/2004
4	Inflammation (Inflammations) 12/2022 - 06/2006
3	Pancreatic Neoplasms (Pancreatic Cancer) 08/2023 - 01/2021
3	Astrocytoma (Pilocytic Astrocytoma) 01/2023 - 10/2004
3	Lung Neoplasms (Lung Cancer) 09/2021 - 01/2020
3	Schistosomiasis (Bilharziasis) 02/2016 - 05/2011
3	Hypoxia (Hypoxemia) 01/2016 - 01/2014
2	Adenocarcinoma 02/2024 - 08/2015
2	Papillary Thyroid Cancer 01/2024 - 12/2020
2	Follicular Adenocarcinoma 01/2024 - 12/2020
2	Thyroid Neoplasms (Thyroid Cancer) 01/2024 - 12/2020
2	Fibrosis (Cirrhosis) 10/2022 - 01/2021
2	Triple Negative Breast Neoplasms 08/2022 - 01/2019
2	Penile Neoplasms (Penile Cancer) 06/2022 - 09/2021
2	Colonic Neoplasms (Colon Cancer) 11/2021 - 01/2014
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2021 - 01/2021
2	Atrophy 01/2021 - 02/2007
2	Multiple Myeloma 01/2021 - 01/2017
2	Pterygium 11/2019 - 01/2016
2	Hypersensitivity (Allergy) 01/2018 - 01/2009
2	Mitochondrial Diseases (Mitochondrial Disease) 04/2016 - 06/2013
2	Ovarian Neoplasms (Ovarian Cancer) 01/2015 - 07/2014
2	Schistosomiasis mansoni 01/2012 - 05/2011
2	Toxoplasmosis 06/2010 - 06/2006
2	Parasitic Diseases (Parasitic Disease) 06/2010 - 02/2007
1	Splenomegaly 12/2023

Drug/Important Bio-Agent (IBA)

37	Galectin 3 (LGALS3)IBA 10/2023 - 10/2004
24	Proteins (Proteins, Gene)FDA Link 08/2023 - 03/2006
11	Messenger RNA (mRNA)IBA 12/2023 - 05/2010
9	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2012
7	Cisplatin (Platino)FDA LinkGeneric 09/2021 - 01/2012
6	MicroRNAs (MicroRNA)IBA 01/2023 - 11/2017
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 05/2010
6	EndostatinsIBA 09/2012 - 10/2007
5	CytokinesIBA 01/2023 - 10/2008
5	LectinsIBA 03/2018 - 08/2008
5	MART-1 AntigenIBA 10/2011 - 04/2005
4	Transcription Factors (Transcription Factor)IBA 02/2024 - 04/2011
4	RNA (Ribonucleic Acid)IBA 01/2024 - 01/2019
4	LipidsIBA 01/2022 - 01/2012
4	IntegrinsIBA 01/2019 - 08/2008
4	ProhibitinsIBA 11/2017 - 06/2013
4	Polysaccharides (Glycans)IBA 12/2016 - 02/2007
4	LigandsIBA 01/2014 - 10/2007
3	Dacarbazine (DIC)FDA LinkGeneric 07/2022 - 05/2010
3	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 07/2009
3	Temozolomide (Temodar)FDA LinkGeneric 10/2019 - 06/2017
3	Fibronectins (Fibronectin)IBA 01/2019 - 12/2006
3	Carrier Proteins (Binding Protein)IBA 01/2018 - 02/2011
3	Bevacizumab (Avastin)FDA Link 01/2017 - 01/2013
3	NucleophosminIBA 01/2014 - 08/2010
2	RacivirIBA 01/2024 - 12/2020
2	Interleukin-4 (Interleukin 4)IBA 01/2023 - 01/2009
2	AntibodiesIBA 12/2022 - 04/2016
2	MelatoninIBA 08/2022 - 01/2019
2	Amino Acids FDA Link 08/2022 - 01/2022
2	Peptides (Polypeptides)IBA 01/2022 - 12/2006
2	Therapeutic UsesIBA 01/2021 - 02/2016
2	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 05/2010
2	Nucleic AcidsIBA 01/2021 - 03/2020
2	Metformin (Glucophage)FDA LinkGeneric 01/2021 - 01/2021
2	tocilizumab (atlizumab)FDA Link 01/2021 - 01/2017
2	Chloroquine (Aralen)FDA LinkGeneric 01/2020 - 03/2018
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 11/2019 - 01/2016
2	ArginaseIBA 10/2019 - 04/2014
2	Interleukin-10 (Interleukin 10)IBA 10/2019 - 06/2010
2	CopperIBA 09/2019 - 10/2013
2	platelet activating factor receptorIBA 10/2018 - 01/2012
2	Cytostatic AgentsIBA 03/2018 - 05/2008
2	Monoclonal AntibodiesIBA 01/2017 - 02/2016
2	CaspasesIBA 04/2016 - 06/2013
2	Glucose (Dextrose)FDA LinkGeneric 10/2015 - 01/2014
2	CarcinogensIBA 12/2014 - 03/2006
2	Galectins (Galectin)IBA 07/2014 - 10/2013
2	KininsIBA 04/2014 - 04/2005
2	beta CateninIBA 01/2014 - 09/2011
2	3' Untranslated Regions (3' UTR)IBA 01/2014 - 06/2013
2	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2013 - 03/2006
2	Annexin A5IBA 05/2011 - 10/2009
2	Interleukin-2 (IL2)IBA 03/2011 - 09/2010
1	Platelet Factor 4IBA 12/2023
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2023
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2023
1	Phosphotransferases (Kinase)IBA 01/2023
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2023
1	PK 11195 (PK11195)IBA 12/2022

Therapy/Procedure

27	Therapeutics 12/2023 - 05/2008
12	Drug Therapy (Chemotherapy) 09/2021 - 01/2012
4	Radiotherapy 01/2023 - 10/2018
2	Immunotherapy 01/2023 - 12/2021
2	Radioimmunotherapy 01/2017 - 01/2015